9.9.13-Bill Jackson Ph.D., CSO at Base Pair Biotechnologies was recently interviewed for an article in the recent edition of CEOCFO Magazine – The Most Powerful Name In Corporate News and Information. Highlights include Bill Jackson Ph.D experience and thoughts on aptamer integration, addressing challenges of a newly available technology, and future direction. If you are interested in reading the articlefind it at With a Patented Multiplexed Approach, Base Pair Biotechnologies Develops Reagents for New Diagnostic Tests and Aptamers for Therapeutics at an Unprecedented Time and Cost
